禽类抗体作为潜在的治疗工具
Mats Eriksson1,2, Anders Larsson3
1Department of Surgical Sciences, Section of Anaesthesiology and Intensive Care, Uppsala University, SE-751 85 Uppsala, Sweden.
Antibodies (Basel, Switzerland)
|February 21, 2025
概括
蛋黄抗体 (免疫球蛋白Y或IgY) 为哺乳动物抗体提供了一种具有成本效益和动物友好的替代品,用于诊断和治疗. IgY显示增强结合和减少干扰,扩大了对抗病原体的选择.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 兽医医学 兽医医学 兽医医学
- 生物技术是生物技术.
背景情况:
- 免疫球蛋白Y (IgY) 是鸟类蛋中占主导地位的抗体,为抗体生产提供了可扩展和经济的来源.
- 与哺乳动物抗体相比,IgY具有生物化学优势,从蛋黄中进行更简单的净化,避免动物因收集血液而遭受痛苦.
- 鸟类和哺乳动物之间的进化分歧使IgY能够识别更广泛的哺乳动物蛋白质表位.
研究的目的:
- 突出免疫球蛋白Y (IgY) 在各种应用中作为哺乳动物抗体的可行替代品的优势.
- 探索IgY在免疫诊断,免疫疗法和对抗微生物感染方面的生化和功能益处.
- 讨论IgY作为研究工具和对病原体的治疗剂的潜力.
主要方法:
- 审查关于免疫球蛋白Y (IgY) 生产,净化和应用的现有文献.
- 对IgY生物化学特性与哺乳动物抗体的比较分析.
- 在临床前和临床研究中对特定病原体的IgY疗效的检查.
主要成果:
- 与其他动物抗体相比,IgY对哺乳动物蛋白质具有优越的结合亲和力,提高了测试灵敏度.
- IgY不会干扰类风湿性因素或人类抗小鼠IgG抗体 (HAMA),减少测试背景噪声.
- IgY的成功应用包括治疗Pseudomonas aeruginosa感染,Streptococcus mutans和肠道感染.
结论:
- 免疫球蛋白Y (IgY) 是一种强效,具有成本效益的抗体,在研究,诊断和治疗方面具有显著的优势.
- 它独特的结合能力和缺乏交叉反应性使其成为免疫学测试中宝贵的工具.
- 虽然由于免疫原性,IgY仅限于非全身管理,但它为各种感染提供了对抗生素有希望的替代品.
关键词:
类 (Gallus gallus domesticus) 是一种类动物.这就是IgYY.伪omonas aeruginosa 这种类型的病毒.抗生素 抗生素是一种抗生素.抗微生物耐药性 抗微生物耐药性囊性纤维化症是什么蛋黄 蛋黄 蛋黄 蛋黄子 子 子免疫球蛋白是一种免疫球蛋白.蛇毒是一种蛇毒.更多相关视频
07:52Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
8.8K
00:09Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
Published on: August 22, 2019
10.6K
相关概念视频
00:42Cross-reactivity
30.9K
Overview
30.9K
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
01:31Hybridoma Technology
14.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.0K